North America's largest chemical trade show is an all encompassing global chemical event featuring a trade show floor, conference sessions, and networking receptions. This premier annual event will bring together motivated buyers and sellers in the fine, specialty, and custom chemical industry from February 14 to 17, 2012 at the Morial Convention Center in New Orleans, LA. Informex will provide numerous opportunities to make new connections, firm up projects with existing suppliers/clients, and learn about the latest trends in the chemical industry. Register today!
Outsourced Pharma will help pharmaceutical companies through the complex vetting process by presenting commentary from industry leaders, trends and analysis, white papers, and in-depth information on key outsourcing providers and their core capabilities.
We welcome your feedback and contributions to this newsletter since it is being produced to serve you. Also, watch for more ways to engage with Outsourced Pharma and the content you need to make solid outsourcing decisions in 2012.
Pharma Beyond Borders: India As An Outsourcing Destination By Manoj Mehrotra, Dr. Reddy's
The only thing that is constant in life (and that goes for the global pharma industry too!) is change. The need to access emerging markets with new and cost effective drugs, the diminishing blockbuster product model, and the far more complicated life cycle management programs are just some of the new and ever changing challenges that innovator pharmaceutical companies face in today's environment.
informEx Booth 1434
Is A CMO With A Global Supply Chain Always The Best Option? By Kate Hammeke, Nice Insight
In the past decade, the pharmaceutical industry has looked to supply chain inefficiencies in order to improve operations and streamline costs. Pharmaceutical companies have learned that partnering with third parties — contract research and contract manufacturing organizations — for certain services increases efficiency and flexibility.
Combination Products 2.0: Applying The New FDA Regulations By Steven Richter, Ph.D, Microtest Laboratories, Inc.
Combination products, those that contain medical devices embedded with pharmaceutical or biologic components,
have become a large and growing segment of the medical device market. Some analysts estimate they represent over 30% of all new product submissions to the FDA.
Understanding Ion Resin Technology By Scott Madsen, Technical Program Manager, Coating Place, Inc.
Ion exchange resins have been in use for many years in pharmaceutical formulations. Their uses have ranged from simple excipients for tablet disintegration to the rate controlling function in extended release formulations. However, efficient drug utilization has been less than ideal historically in the formation of drug-resin complexes to be used in pharmaceutical products.
Clinical Trial Outsourcing: Why China? By Mike Anello, Life Science Leader magazine
Recent trends show that an ever-increasing percentage of clinical trials are being performed offshore. As the pressure increases to reduce the cost of prescription drugs, pharmaceutical manufacturers search for ways to reduce costs in research and production.
Aseptic/sterile production and injectable manufacturing processes require a significant investment in terms of expertise, equipment, process, technology and quality control. Pfizer facilities and expertise can create a cost-effective solution.
With Alkermes Contract Pharma Services, you have the opportunity to outsource your development, scale-up, and manufacturing requirements to a trusted, experienced, and dedicated expert in outsourcing services.
Kemwell Biopharma will offer services ranging from full-service process development, manufacture, formulation, and fill and finish at the cGMP manufacturing facility in Bangalore, India. This is a one-stop-shop, through access to Boehringer Ingelheim's® cell line development with the BI HEX technology platform, followed by preferred access to the large-scale commercial production by Boehringer Ingelheim at its facilities in Europe.